Overview
Research | Process | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
---|---|---|---|---|---|---|---|---|
ALT-P1 | Long-acting Human Growth Hormone | ![]() |
![]() |
![]() |
![]() |
![]() |
||
Domestic Phase II in Progress / Preparation of global Phase II | ||||||||
ALT-Q2 | Long-acting Factor Vlla | ![]() |
![]() |
|||||
Process Development in Progress | ||||||||
ALT-P7 | Breast/Gastric Cancer ADC | ![]() |
![]() |
![]() |
![]() |
|||
Preparation of Phase II Clinical Trial | ||||||||
ALT-Q5 | Ovarian Cancer ADC | ![]() |
![]() |
|||||
Process Development in Progress | ||||||||
ALT-L9 | Eylea Biosimilar | ![]() |
![]() |
![]() |
![]() |
|||
First-in-class Domestic Phase I Clinical Trial in Progress | ||||||||
ALT-L2 | Herceptin Biosimilar | ![]() |
![]() |
![]() |
![]() |
![]() |
||
Preparation of Global Phase III Clinical Trial | ||||||||
ALT-LS2 | Herceptin SC Biosimilar | ![]() |
![]() |
|||||
Process Development in Progress |
